https://www.rttnews.com/story.aspx?Id=3429912
Mar 05, 2024 - After ending the previous session modestly lower, stocks may see further downside in early trading on Tuesday. The major index futures are currently pointing to initial weakness on Wall Street, with the S&P 500 futures down by 0.4 percent.
0
rttnews:7072202401063335998
0
https://www.zacks.com/stock/news/2235661/dave-buster-s-play-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2235661
Mar 04, 2024 - In the latest trading session, Dave & Buster's (PLAY) closed at $61.30, marking a -1.89% move from the previous day.
zc:6188829298410865297
0
https://seekingalpha.com/article/4675595-capgemini-good-cost-control-still-seeing-slow-cycles-new-genai-conversations?source=feed_all_articles
Mar 03, 2024 - Capgemini is a tech consulting company with a focus on Europe and is preparing for better years driven by solid bookings. Read why CAPMF stock is a Hold.
0
sa:-6324599992821907156
0
https://www.rttnews.com/story.aspx?Id=3429178
Mar 01, 2024 - Stocks have moved mostly higher during trading on Friday, with the Nasdaq and the S&P 500 on pace to set new record closing highs. The major averages have all moved to the upside, with the tech-heavy Nasdaq leading the advance. The advance by the Nasdaq partly reflects substantial strength among computer hardware stocks following upbeat results from Dell.
0
rttnews:7072194401049335978
0
https://www.zacks.com/stock/news/2234650/wall-street-analysts-see-a-58-85-upside-in-arcutis-biotherapeutics-inc-arqt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2234650
Mar 01, 2024 - The consensus price target hints at a 58.9% upside potential for Arcutis Biotherapeutics, Inc. (ARQT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zc:-5932315997448686151
0
https://www.zacks.com/stock/news/2234548/wall-street-analysts-see-arista-networks-anet-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2234548
Mar 01, 2024 - Based on the average brokerage recommendation (ABR), Arista Networks (ANET) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-2788263352558432033
0
https://www.zacks.com/stock/news/2234557/wall-street-analysts-see-ani-anip-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2234557
Mar 01, 2024 - Based on the average brokerage recommendation (ABR), ANI (ANIP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-7535076525338449367
0
https://www.cnbc.com/2024/02/28/bitcoin-etfs-see-record-high-trading-volumes-as-retail-investors-jump-on-crypto-rally.html
Feb 28, 2024 - The iShares Bitcoin Trust (IBIT) has already seen a record number of shares traded on Wednesday.
0
cnbc:-7577379659541337241
0
https://www.zacks.com/stock/news/2233166/wall-street-analysts-see-bitfarms-ltd-bitf-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2233166
Feb 28, 2024 - Based on the average brokerage recommendation (ABR), Bitfarms Ltd. (BITF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-1346928436651249695
0
https://www.nrn.com/news/cracker-barrel-ceo-julie-felss-masino-sees-long-road-ahead-q2-traffic-dips-4
Feb 27, 2024 - The Tennessee-based casual-dining brand will focus on its new loyalty program, as well as strategic pricing and labor reductions, to improve the bottom line
0
nrn:3005202414973069650
0